Department of Pharmaceutical Sciences


April 18, 2017

UAMS’ Peter Crooks, Ph.D., D.Sc. Named Fellow of the National Academy of Inventors

Ben Boulden

April 18, 2017 | Peter Crooks, Ph.D., D.Sc., chair and professor of the Department of Pharmaceutical Sciences in the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy, recently was named a Fellow of the National Academy of Inventors (NAI). Being named a Fellow recognizes NAI members who have, according to the academy, “demonstrated…


January 17, 2017

Study Shows Chemotherapy Induces Cellular Aging, Which Promotes Side Effects, Cancer Relapse

Ben Boulden

Jan. 17, 2017 | Chemotherapy for cancer causes a pro-inflammatory stress response that promotes adverse side effects and cancer relapse, says a research team that includes the University of Arkansas for Medical Sciences (UAMS). Daohong Zhou, M.D., associate director for basic research in the UAMS Winthrop P. Rockefeller Cancer Institute, is a co-author of the study…


September 1, 2016

Radiation Effects Expert Martin Hauer-Jensen Invested in J. Thomas May Distinguished Endowed Chair in Oncology

Benjamin Waldrum

Martin Hauer-Jensen, M.D., Ph.D., is presented with a chair as part of the investiture ceremony, while College of Pharmacy Dean Keith M. Olsen, Pharm.D., and Chancellor Dan Rahn, M.D., look on.

Sept. 1, 2016 | The family of the late William E. “Bill” Clark has given $300,000 to establish a distinguished endowed chair in honor of J. Thomas May in which world-renowned radiation effects expert Martin Hauer-Jensen, M.D., Ph.D., was invested Aug. 29 at the University of Arkansas for Medical Sciences (UAMS). Hauer-Jensen, a professor of…


August 12, 2015

UAMS Researchers Awarded $10.5 Million to Establish Center

Ben Boulden

UAMS researchers, led by Martin Hauer-Jensen, M.D., have secured a $10.5 million grant to establish a center to study side effects of cancer therapy.


UAMS Researchers Awarded $10.5 Million Grant to Establish Center for Study of Cancer-Therapy Toxicity

Ben Boulden

LITTLE ROCK – A team of UAMS researchers has secured a $10.5 million grant to establish a center to study side effects of of cancer therapy.